(Q36053911)

English

Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease (English)

1 reference

Europe PubMed Central

11 August 2017

1 reference

based on heuristic

inferred from title

chronic liver disease

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Y Khaliq

1

1 reference

Europe PubMed Central

11 August 2017

K Gallicano

2

1 reference

Europe PubMed Central

11 August 2017

I Seguin

3

1 reference

Europe PubMed Central

11 August 2017

K Fyke

4

1 reference

Europe PubMed Central

11 August 2017

G Carignan

5

1 reference

Europe PubMed Central

11 August 2017

D Bulman

6

1 reference

Europe PubMed Central

11 August 2017

A Badley

7

1 reference

Europe PubMed Central

11 August 2017

D W Cameron

8

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

11 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

11 August 2017

50

1 reference

Europe PubMed Central

11 August 2017

108-115

1 reference

Europe PubMed Central

11 August 2017

2

1 reference

Europe PubMed Central

11 August 2017

A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

Nelfinavir mesylate: a protease inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

Protein binding drug displacement interactions fact or fiction?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

2 October 2017

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

23 September 2018

Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

23 September 2018

Lack of pharmacokinetic interaction between nelfinavir and nevirapine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

23 September 2018

The pharmacokinetics of combination therapy with nelfinavir plus nevirapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014390

23 September 2018

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/10930962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10930962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosage adjustment of antiretroviral agents in patients with organ dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10930962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/10930962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drugs and the liver. Symposium proceedings. 21-24 April 1998

1 reference

https://pubmed.ncbi.nlm.nih.gov/10930962

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2125.2000.00238.X

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36053911&oldid=1641902687"